(Reuters) -Tylenol maker Kenvue said on Monday that Johnson & Johnson will sell its remaining 9.5% stake in the company, ...
Tylenol maker Kenvue said on Monday that Johnson & Johnson will offload its entire 9.5% stake in the company, about a year ...
, opens new tab will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business. Based on Kenvue stock's last ...
Un año después del spin-off de su negocio de consumo, Johnson & Johnson anunció hoy que venderá lo que queda de su participación en Kenvue. Ofrecerá sus 182,33 millones de acciones restantes por deuda ...
La multinacional estadounidense Johnson & Johnson (J&J) se desprenderá de la participación del 9,5% que aún controlaba en Kenvue, su antiguo negocio de higiene personal y productos de consumo ...
Tylenol maker Kenvue has said that Johnson & Johnson will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.